Top Markets
Coin of the day
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Pozycja w akcjach #41009
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm,... MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health. The company's product pipeline features several key developments: MCT-125: This investigational therapy is currently in Phase II clinical trials, targeting the primary fatigue commonly associated with multiple sclerosis. MCT-465: A preclinical-stage synthetic double-stranded RNA (dsRNA) candidate, designed to act as a powerful immune enhancer for the treatment of solid tumor malignancies. MCT-485: Another dsRNA therapeutic, still in the discovery phase, which demonstrates tumor cytolytic (cell-destroying) properties, intended for use against diverse cancers. Beyond drug candidates, MultiCell Technologies is also progressing the Ideal BioStent, an innovative bioabsorbable stent specifically engineered for use in interventional cardiology and peripheral vessel procedures. The organization maintains licensing agreements with prominent entities such as Corning Incorporated and Pfizer Inc. Established in 1962, the company was previously known as Exten Industries, Inc. before officially changing its name to MultiCell Technologies, Inc. in April 2004. Its corporate headquarters are situated in Woonsocket, Rhode Island.
Cena akcji
$0.00001
Ostatnia synchronizacja: 2026-09-10
Kapitalizacja rynkowa
$50.01K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel MultiCell Technologies, Inc. (MCET)

Kategoria

Historia ceny akcji dla MultiCell Technologies, Inc. (MCET)
Najwyższa cena zamknięcia: $0.00 dnia 2026-09-01

Najniższa cena zamknięcia: $0.70 dnia 2000-01-01
Historia cen akcji firmy MultiCell Technologies, Inc. od 2000 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 -89.96%
2024 542.72%
2023 -58.24%
2022 0.00%
2021 -58.10%
2020 156.99%
2019 -7.14%
2018 -41.18%
2017 -16.78%
2016 -6.37%
2015 -36.84%
2014 -38.00%
2013 -58.42%
2012 -72.33%
2011 13.46%
2010 -68.39%
2009 150.51%
2008 -86.27%
2007 -83.63%
2006 -60.50%
2005 -31.77%
2004 -70.68%
2003 719.22%
2002 -33.40%
2001 -14.26%
2000 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$515.86 30.75%
US
$987.47 30.55%
NL
$146.64 523.73%
US
$117.15 -15.24%
AU
$690.34 0.44%
CH